These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 24562613

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ceftazidime-avibactam and comparator agents tested against urinary tract isolates from a global surveillance program (2011).
    Flamm RK, Sader HS, Farrell DJ, Jones RN.
    Diagn Microbiol Infect Dis; 2014 Nov; 80(3):233-8. PubMed ID: 25128477
    [Abstract] [Full Text] [Related]

  • 3. Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia.
    Sader HS, Castanheira M, Flamm RK, Mendes RE, Farrell DJ, Jones RN.
    Int J Antimicrob Agents; 2015 Jul; 46(1):53-9. PubMed ID: 25956844
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of ceftazidime/avibactam against Gram-negative pathogens isolated from pneumonia in hospitalised patients, including ventilated patients.
    Flamm RK, Nichols WW, Sader HS, Farrell DJ, Jones RN.
    Int J Antimicrob Agents; 2016 Mar; 47(3):235-42. PubMed ID: 26920105
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ceftazidime-Avibactam Activity against Aerobic Gram Negative Organisms Isolated from Intra-Abdominal Infections in United States Hospitals, 2012-2014.
    Sader HS, Castanheira M, Flamm RK, Huband MD, Jones RN.
    Surg Infect (Larchmt); 2016 Aug; 17(4):473-8. PubMed ID: 27104633
    [Abstract] [Full Text] [Related]

  • 8. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.
    Sader HS, Castanheira M, Flamm RK.
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28069649
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of ceftazidime, ceftaroline and aztreonam alone and in combination with avibactam against European Gram-negative and Gram-positive clinical isolates.
    Testa R, Cantón R, Giani T, Morosini MI, Nichols WW, Seifert H, Stefanik D, Rossolini GM, Nordmann P.
    Int J Antimicrob Agents; 2015 Jun; 45(6):641-6. PubMed ID: 25748553
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Avibactam reverts the ceftazidime MIC90 of European Gram-negative bacterial clinical isolates to the epidemiological cut-off value.
    Flamm RK, Stone GG, Sader HS, Jones RN, Nichols WW.
    J Chemother; 2014 Dec; 26(6):333-8. PubMed ID: 24125508
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial activity of ceftazidime-avibactam against Gram-negative organisms collected from U.S. medical centers in 2012.
    Sader HS, Castanheira M, Flamm RK, Farrell DJ, Jones RN.
    Antimicrob Agents Chemother; 2014 Dec; 58(3):1684-92. PubMed ID: 24379201
    [Abstract] [Full Text] [Related]

  • 14. Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012).
    Farrell DJ, Sader HS, Flamm RK, Jones RN.
    Int J Antimicrob Agents; 2014 Jun; 43(6):533-9. PubMed ID: 24856078
    [Abstract] [Full Text] [Related]

  • 15. Activity of ceftazidime-avibactam against fluoroquinolone-resistant Enterobacteriaceae and Pseudomonas aeruginosa.
    Pitart C, Marco F, Keating TA, Nichols WW, Vila J.
    Antimicrob Agents Chemother; 2015 Jun; 59(6):3059-65. PubMed ID: 25753646
    [Abstract] [Full Text] [Related]

  • 16. Ceftazidime-avibactam for the treatment of complicated urinary tract infections and complicated intra-abdominal infections.
    Mawal Y, Critchley IA, Riccobene TA, Talley AK.
    Expert Rev Clin Pharmacol; 2015 Jun; 8(6):691-707. PubMed ID: 26420166
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial Activity of Ceftazidime-Avibactam Against Contemporary Pathogens From Urinary Tract Infections and Intra-abdominal Infections Collected From US Children During the 2016-2019 INFORM Surveillance Program.
    Lin LY, Riccobene T, Debabov D.
    Pediatr Infect Dis J; 2021 Apr 01; 40(4):338-343. PubMed ID: 33395207
    [Abstract] [Full Text] [Related]

  • 18. Antimicrobial Susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa Isolates from United States Medical Centers Stratified by Infection Type: Results from the International Network for Optimal Resistance Monitoring (INFORM) Surveillance Program, 2015-2016.
    Sader HS, Castanheira M, Duncan LR, Flamm RK.
    Diagn Microbiol Infect Dis; 2018 Sep 01; 92(1):69-74. PubMed ID: 29789189
    [Abstract] [Full Text] [Related]

  • 19. Ceftazidime-Avibactam Antimicrobial Activity and Spectrum When Tested Against Gram-negative Organisms From Pediatric Patients: Results From the INFORM Surveillance Program (United States, 2011-2015).
    Sader HS, Huband MD, Duncan LR, Flamm RK.
    Pediatr Infect Dis J; 2018 Jun 01; 37(6):549-554. PubMed ID: 29206750
    [Abstract] [Full Text] [Related]

  • 20. In Vitro Activity of Ceftazidime-Avibactam against Isolates from Respiratory and Blood Specimens from Patients with Nosocomial Pneumonia, Including Ventilator-Associated Pneumonia, in a Phase 3 Clinical Trial.
    Stone GG, Bradford PA, Tawadrous M, Taylor D, Cadatal MJ, Chen Z, Chow JW.
    Antimicrob Agents Chemother; 2020 Apr 21; 64(5):. PubMed ID: 32071051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.